Radium Bromatum 8 X Globules ; Granules ; Liquid is a Health Canada–registered human drug (DIN 02236418) held by Dolisos Canada Inc., containing Radium Bromide. Health Canada lists its status as Cancelled Post Market (status date 12 Aug 1999). Nexara Health has matched 8 registrations of Radium Bromide across 5 other regulated markets.
Health Canada registration
| DIN | 02236418 |
|---|---|
| Brand name | Radium Bromatum |
| Active ingredient | Radium Bromide |
| Strength | 8 X |
| Dosage form | Globules ; Granules ; Liquid |
| Route | Oral |
| Company | Dolisos Canada Inc. |
| Status | Cancelled Post Market — 12 Aug 1999 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Radium Bromide registered in other markets
8 registrations of the same molecule in 5 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Greece | XOFIGO INJ.SOL 1100kBq/ML 1VIALx6ML | Bayer AG, Leverkusen, Germany | reimbursed | MoH deltio timwn | ||
| Ireland | Xofigo 1100 kBq/mL solution for injection | Bayer AG | Solution for injection | Unknown | HPRA | |
| Singapore | XOFIGO SOLUTION FOR INJECTION 1100kBq/ML | Bayer (South East Asia) Pte Ltd | 1100 kBq/ml | Injection, Solution (Radiopharmaceutical) | Prescription Only | HSA |
| Taiwan | Xofigo solution for injection | Agilera Pharma AS | 注射液劑 | Registered | TFDA | |
| United States | Radium bromatum | Boiron | Pellet | listed | FDA NDC | |
| United States | Radium bromatum | Boiron | Pellet | listed | FDA NDC | |
| United States | Radium bromatum | Boiron | Pellet | listed | FDA NDC | |
| United States | Radium bromatum | Boiron | Pellet | listed | FDA NDC |
See every manufacturer of Radium Bromide worldwide →
Regulator price references for Radium Bromide
Published list or reimbursement prices for Radium Bromide presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Greece | XOFIGO INJ.SOL 1100kBq/ML 1VIALx6ML | 6ml | 3,808.68 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Radium Bromatum (DIN 02236418) marketed in Canada?
No. Health Canada lists DIN 02236418 as Cancelled Post Market as of 12 Aug 1999.
Who holds the Canadian licence for this product?
Dolisos Canada Inc. is the company of record in the Health Canada Drug Product Database.
Is Radium Bromide registered outside Canada?
Yes — Nexara Health has matched 8 registrations in 5 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02236418, status date 1999-08-12; national medicine registries: FDA NDC, HPRA, HSA, MoH deltio timwn, TFDA; price sources: MoH deltio timwn. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02236418, status date 1999-08-12; national medicine registries: FDA NDC, HPRA, HSA, MoH deltio timwn, TFDA; price sources: MoH deltio timwn.
Health Canada Drug Product Database (DPD), DIN 02236418, status date 1999-08-12; national medicine registries: FDA NDC, HPRA, HSA, MoH deltio timwn, TFDA; price sources: MoH deltio timwn. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.